Search Results - "Rennels, Aaron D."

Abacavir induces loading of novel self-peptides into HLA-B57:01: an autoimmune model for HLA-associated drug hypersensitivity by NORCROSS, Michael A, SHEN LUO, HILDEBRAND, William H, BUCHLI, Rico, LI LU, BOYNE, Michael T, COMARTELI, Mary, RENNELS, Aaron D, WOODCOCK, Janet, MARGULIES, David H, MCMURTREY, Curtis, VERNON, Stephen

“…Abacavir drug hypersensitivity in HIV-treated patients is associated with HLA-B57:01 expression. To understand the immunochemistry of abacavir drug reactions,…”
Get full text

55-OR by Buchli, Rico, Caseltine, Shannon L, McAdams, Rebecca D, VanGundy, Rodney S, Wichner, Timea, Rennels, Aaron D, Yaciuk, Jane C, Duquesnoy, Rene J, Weidanz, Jon, Hildebrand, William H

“…Aim The apparent clinical and research utility of soluble HLA (sHLA) underscores the need to further investigate immunological effects triggered by injections…”
Get full text

9-P by McAdams, Rebecca D, Lira, Kayla M, VanGundy, Rodney S, Eades, Michael C, Sigler, Steffan D, Rennels, Aaron D, Hildebrand, William H, Buchli, Rico

“…Aim Solid phase antibody detection assays are used in most clinical histocompatibility laboratories. Recent studies have shown that current methodologies can…”
Get full text

8-P by Sigler, Steffan D, McAdams, Rebecca D, Lira, Kayla M, VanGundy, Rodney S, Eades, Michael C, Rennels, Aaron D, Hildebrand, William H, Buchli, Rico

“…Aim Degraded or denatured HLA proteins can contribute to false positive, false negative, and inconsistent MFI signals. To provide recommendations for…”
Get full text

10-P by VanGundy, Rodney S, Eades, Michael C, McAdams, Rebecca D, McMurtrey, Curtis P, Cate, Steven J, Lira, Kayla M, Sigler, Steffan D, Rennels, Aaron D, Hildebrand, William H, Buchli, Rico

“…Aim Many sensitized transplant patients have HLA-specific antibodies due to previous graft failures, blood transfusions, and pregnancies. These humoral…”
Get full text

81-P by Eades, Michael C, VanGundy, Rodney S, McAdams, Rebecca D, McMurtrey, Curtis P, Cate, Steven J, Sigler, Steffan D, Rennels, Aaron D, Lira, Kayla M, Hildebrand, William H, Buchli, Rico

“…Aim Therapies exist for the bulk removal of antibodies in sensitized transplant patients, but there are no means to specifically deplete antibodies that…”
Get full text

7-P by Lira, Kayla M, McAdams, Rebecca D, VanGundy, Rodney S, Eades, Michael C, Sigler, Steffan D, Rennels, Aaron D, Hildebrand, William H, Buchli, Rico

“…Aim Solid phase antibody detection assays using single antigens represent a cutting edge technology for screening the sera of transplant patients. Considering…”
Get full text

10-OR by Buchli, Rico, McAdams, Rebecca, Rennels, Aaron D., VanGundy, Rodney S., Hildebrand, William H.

Get full text

10-OR: NEW APPROACHES TO DEFINE BINDING MOTIFS AND SUPERTYPES IN PEPTIDE BINDING ANALYSIS by Buchli, Rico, McAdams, Rebecca, Rennels, Aaron D., VanGundy, Rodney S., Hildebrand, William H.

“…Classification of allele overlapping peptide-binding specificities has become an important issue in vaccine design with direct implications concerning…”
Get full text

10-OR by Buchli, Rico, McAdams, Rebecca, Rennels, Aaron D, VanGundy, Rodney S, Hildebrand, William H

“…Aim Classification of allele overlapping peptide-binding specificities has become an important issue in vaccine design with direct implications concerning…”
Get full text

55-OR: HLA IMMUNE RESPONSE MONITORING – SOLUBLE HLA IMMUNOGENICITY EVALUATION IN A MOUSE MODEL by Buchli, Rico, Caseltine, Shannon L., McAdams, Rebecca D., VanGundy, Rodney S., Wichner, Timea, Rennels, Aaron D., Yaciuk, Jane C., Duquesnoy, Rene J., Weidanz, Jon, Hildebrand, William H.

“…The apparent clinical and research utility of soluble HLA (sHLA) underscores the need to further investigate immunological effects triggered by injections into…”
Get full text

21-OR by VanGundy, Rodney S., McAdams, Rebecca D., Lira, Kayla M., Eades, Michael C., Cate, Steven J., McMurtrey, Curtis P., Sigler, Steffan D., Rennels, Aaron D., Hildebrand, William H., Buchli, Rico

Get full text

21-OR: SOLUBLE HLA – A NEW GENERATION OF SINGLE ANTIGEN ASSAYS by VanGundy, Rodney S., McAdams, Rebecca D., Lira, Kayla M., Eades, Michael C., Cate, Steven J., McMurtrey, Curtis P., Sigler, Steffan D., Rennels, Aaron D., Hildebrand, William H., Buchli, Rico

“…While it is generally accepted that HLA antibodies represent significant risk factors for transplant rejection and graft failure, it has become apparent that…”
Get full text

81-P: THE MAKING OF ANTI-HLA ANTIBODY REMOVAL MATRICES – A PERFORMANCE STUDY by Eades, Michael C., VanGundy, Rodney S., McAdams, Rebecca D., McMurtrey, Curtis P., Cate, Steven J., Sigler, Steffan D., Rennels, Aaron D., Lira, Kayla M., Hildebrand, William H., Buchli, Rico

“…Therapies exist for the bulk removal of antibodies in sensitized transplant patients, but there are no means to specifically deplete antibodies that recognize…”
Get full text

21-OR by VanGundy, Rodney S, McAdams, Rebecca D, Lira, Kayla M, Eades, Michael C, Cate, Steven J, McMurtrey, Curtis P, Sigler, Steffan D, Rennels, Aaron D, Hildebrand, William H, Buchli, Rico

“…Aim While it is generally accepted that HLA antibodies represent significant risk factors for transplant rejection and graft failure, it has become apparent…”
Get full text

Mining for Treasures: Systematic Profiling of 8-, 9-, 10-, and 11-mer HLA-B0702-restricted CD8+ T cell epitopes from the Influenza A/Puerto Rico/8/34 (H1N1) Virus Hemagglutinin with Potential Application in Vaccine Development (B193) by Buchli, Rico, VanGundy, Rodney S., Plompen, Sonja, Rennels, Aaron D., Ede, Nicholas J., Hildebrand, William H.

“…Abstract Identification of T cell epitopes is of crucial importance for the development of cancer and viral T cell eliciting vaccines. Here, we define CD8+ T…”
Get full text